Communique #37
29 January, 2021
Following a well-earned break, the Taskforce team has now returned to full capacity. Global evidence surveillance continued throughout January, with six clinical panel meetings held since January 11. We look forward to continuing to keep Australian clinicians armed with the latest evidence-based guidance for the treatment of people with COVID-19. WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE Taskforce...